Beatriz Seoane

637 total citations
28 papers, 480 citations indexed

About

Beatriz Seoane is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Animal Science and Zoology. According to data from OpenAlex, Beatriz Seoane has authored 28 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 21 papers in Physiology and 8 papers in Animal Science and Zoology. Recurrent topics in Beatriz Seoane's work include Asthma and respiratory diseases (21 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (17 papers) and Respiratory and Cough-Related Research (12 papers). Beatriz Seoane is often cited by papers focused on Asthma and respiratory diseases (21 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (17 papers) and Respiratory and Cough-Related Research (12 papers). Beatriz Seoane collaborates with scholars based in Spain, United Kingdom and United States. Beatriz Seoane's co-authors include Diana Jarreta, Cynthia Caracta, Jutta Beier, Esther García Gil, Anne‐Marie Kirsten, Gonzalo de Miquel, Bartolomé R. Celli, Richard Casaburi, François Maltais and János Pórszász and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and Archives of Disease in Childhood.

In The Last Decade

Beatriz Seoane

25 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beatriz Seoane Spain 11 387 324 58 56 41 28 480
Rosario Melchor Spain 8 291 0.8× 204 0.6× 21 0.4× 10 0.2× 16 404
John Kottakis United Kingdom 16 644 1.7× 576 1.8× 15 0.3× 7 0.1× 19 679
Denise Till Switzerland 7 571 1.5× 489 1.5× 8 0.1× 6 0.1× 11 595
Lawrence Korducki United States 13 813 2.1× 697 2.2× 5 0.1× 10 0.2× 39 841
M. Reza Maleki-Yazdi Canada 11 575 1.5× 464 1.4× 5 0.1× 17 0.3× 1 0.0× 21 610
Achim Mueller United States 11 784 2.0× 631 1.9× 15 0.3× 21 0.4× 21 873
Selwyn Spangenthal United States 10 264 0.7× 210 0.6× 4 0.1× 10 0.2× 16 316
J Małolepszy Poland 6 349 0.9× 374 1.2× 7 0.1× 6 0.1× 10 452
Gonzalo de Miquel Spain 10 371 1.0× 300 0.9× 3 0.1× 9 0.2× 24 407
Joseph Aumann Belgium 10 490 1.3× 407 1.3× 3 0.1× 22 0.4× 18 523

Countries citing papers authored by Beatriz Seoane

Since Specialization
Citations

This map shows the geographic impact of Beatriz Seoane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatriz Seoane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatriz Seoane more than expected).

Fields of papers citing papers by Beatriz Seoane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatriz Seoane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatriz Seoane. The network helps show where Beatriz Seoane may publish in the future.

Co-authorship network of co-authors of Beatriz Seoane

This figure shows the co-authorship network connecting the top 25 collaborators of Beatriz Seoane. A scholar is included among the top collaborators of Beatriz Seoane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatriz Seoane. Beatriz Seoane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Psallidas, Ioannis, Carol Astbury, Beatriz Seoane, et al.. (2018). Pharmacodynamic and pharmacokinetic results after repeated doses of AZD8871 in COPD patients. OA1656–OA1656. 1 indexed citations
5.
Wise, Robert A., Kenneth R. Chapman, Benjamin M. Scirica, et al.. (2017). Long-Term Evaluation of the Effects of Aclidinium Bromide on Major Adverse Cardiovascular Events and COPD Exacerbations in Patients with Moderate to Very Severe COPD: Rationale and Design of the ASCENT COPD Study. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 5(1). 5–15. 6 indexed citations
6.
7.
Vogelmeier, Claus, Pier Luigi Paggiaro, Jordi Dorca, et al.. (2016). Efficacy and safety of aclidinium/formoterolversussalmeterol/fluticasone: a phase 3 COPD study. European Respiratory Journal. 48(4). 1030–1039. 75 indexed citations
8.
9.
Pascual-Guàrdia, Sergi, Anthony De Soyza, John Haughney, et al.. (2015). Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study. npj Primary Care Respiratory Medicine. 25(1). 15018–15018. 29 indexed citations
10.
Beier, Jutta, et al.. (2014). Abediterol (LAS100977), a novel long-acting β2-agonist: Efficacy, safety and tolerability in persistent asthma. Respiratory Medicine. 108(10). 1424–1429. 13 indexed citations
11.
Beier, Jutta, et al.. (2014). Abediterol in stable asthma:efficacy, safety and tolerability results from a Phase II, randomised, crossover study. European Respiratory Journal. 44(Suppl 58). P902–P902. 3 indexed citations
12.
13.
Beier, Jutta, et al.. (2013). Efficacy and safety of abediterol (LAS100977) in patients with COPD: Phase II, randomised, crossover study. European Respiratory Journal. 42(Suppl 57). 183–183. 6 indexed citations
14.
Palen, Job van der, Paul van der Valk, Laura Padullés, et al.. (2013). Preference, satisfaction and errors with two dry powder inhalers in patients with COPD. Expert Opinion on Drug Delivery. 10(8). 1023–1031. 58 indexed citations
15.
Merino, Nelsón, et al.. (2012). A new technique for fast and safe collection of urine in newborns. Archives of Disease in Childhood. 98(1). 27–29. 61 indexed citations
16.
Singh, Dave, H Magnussen, Anne‐Marie Kirsten, et al.. (2012). A randomised, placebo- and active-controlled dose-finding study of aclidinium bromide administered twice a day in COPD patients. Pulmonary Pharmacology & Therapeutics. 25(3). 248–253. 36 indexed citations
17.
Palen, Job van der, Paul van der Valk, Laura Padullés, et al.. (2012). Preference, satisfaction and critical errors with Genuair® and HandiHaler® in patients with COPD. 40. 2177. 5 indexed citations
18.
Palen, Job van der, Paul van der Valk, Laura Padullés, et al.. (2012). Comparison of the Preference, Satisfaction, and Critical Errors Made With Genuair® and HandiHaler® in patients with COPD. CHEST Journal. 142(4). 717A–717A. 2 indexed citations
19.
Maltais, François, Bartolomé R. Celli, Richard Casaburi, et al.. (2010). Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD. Respiratory Medicine. 105(4). 580–587. 82 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosario Melchor Breakdown of academic impact, for papers by John Kottakis Breakdown of academic impact, for papers by Denise Till Breakdown of academic impact, for papers by Lawrence Korducki Breakdown of academic impact, for papers by M. Reza Maleki-Yazdi Breakdown of academic impact, for papers by Achim Mueller Breakdown of academic impact, for papers by Selwyn Spangenthal Breakdown of academic impact, for papers by J Małolepszy Breakdown of academic impact, for papers by Gonzalo de Miquel Breakdown of academic impact, for papers by Joseph Aumann
Rankless by CCL
2026